1. Home
  2. BIVI vs TKLF Comparison

BIVI vs TKLF Comparison

Compare BIVI & TKLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIVI
  • TKLF
  • Stock Information
  • Founded
  • BIVI 2013
  • TKLF 2006
  • Country
  • BIVI United States
  • TKLF Japan
  • Employees
  • BIVI N/A
  • TKLF N/A
  • Industry
  • BIVI Biotechnology: Pharmaceutical Preparations
  • TKLF Other Specialty Stores
  • Sector
  • BIVI Health Care
  • TKLF Consumer Discretionary
  • Exchange
  • BIVI Nasdaq
  • TKLF Nasdaq
  • Market Cap
  • BIVI 15.0M
  • TKLF 15.7M
  • IPO Year
  • BIVI N/A
  • TKLF 2022
  • Fundamental
  • Price
  • BIVI $1.60
  • TKLF $3.55
  • Analyst Decision
  • BIVI
  • TKLF
  • Analyst Count
  • BIVI 0
  • TKLF 0
  • Target Price
  • BIVI N/A
  • TKLF N/A
  • AVG Volume (30 Days)
  • BIVI 434.0K
  • TKLF 3.8K
  • Earning Date
  • BIVI 08-15-2025
  • TKLF 07-10-2025
  • Dividend Yield
  • BIVI N/A
  • TKLF N/A
  • EPS Growth
  • BIVI N/A
  • TKLF N/A
  • EPS
  • BIVI N/A
  • TKLF 1.57
  • Revenue
  • BIVI N/A
  • TKLF $210,119,238.00
  • Revenue This Year
  • BIVI N/A
  • TKLF N/A
  • Revenue Next Year
  • BIVI N/A
  • TKLF N/A
  • P/E Ratio
  • BIVI N/A
  • TKLF $2.26
  • Revenue Growth
  • BIVI N/A
  • TKLF 7.38
  • 52 Week Low
  • BIVI $1.46
  • TKLF $2.20
  • 52 Week High
  • BIVI $75.00
  • TKLF $7.20
  • Technical
  • Relative Strength Index (RSI)
  • BIVI 21.13
  • TKLF 40.60
  • Support Level
  • BIVI $1.46
  • TKLF $3.53
  • Resistance Level
  • BIVI $1.84
  • TKLF $3.84
  • Average True Range (ATR)
  • BIVI 0.40
  • TKLF 0.21
  • MACD
  • BIVI 0.02
  • TKLF -0.02
  • Stochastic Oscillator
  • BIVI 3.08
  • TKLF 44.00

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

About TKLF Yoshitsu Co. Ltd

Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores, Online Stores and Services, and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from Hong Kong, followed by Japan, the United States, and other overseas markets.

Share on Social Networks: